Search research articles
Contact Us
Filters
Showing results (291-300 of 441) with videos related to
Page
of 45
Sort By:
Transplantation
|
March 22, 2018
Transmission of Hepatitis E Virus With Plasma Exchange in Kidney Transplant Recipients: A Retrospective Cohort Study
Vincent Mallet, Rebecca Sberro-Soussan, Anne-Marie Roque-Afonso, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
August 29, 2024
Alcohol Rehabilitation Within 3 Months After Alcohol Hepatitis and Survival: A National Analysis
Lucia Parlati, Charlotte Mouliade, Eric Nguyen Khac, et al.
Gastro Hep Advances
|
August 12, 2024
External Validation of LCR1-LCR2, a Multivariable Hepatocellular Carcinoma Risk Calculator, in a Multiethnic Cohort of Patients With Chronic Hepatitis B
Thierry Poynard, Jean Marc Lacombe, Olivier Deckmyn, et al.
Lancet (London, England)
|
April 4, 2015
Ombitasvir plus paritaprevir plus ritonavir with or without ribavirin in treatment-naive and treatment-experienced patients with genotype 4 chronic hepatitis C virus infection (PEARL-I): a randomised, open-label trial
Christophe Hézode, Tarik Asselah, K Rajender Reddy, et al.
JHEP Reports : Innovation in Hepatology
|
June 18, 2021
External validation of LCR1-LCR2, a multivariable HCC risk calculator, in patients with chronic HCV
Thierry Poynard, Jean Marc Lacombe, Olivier Deckmyn, et al.
European Journal of Gastroenterology & Hepatology
|
October 19, 2004
Histological response in patients treated by interferon plus ribavirin for hepatitis C virus-related severe fibrosis
Armand Abergel, Claude Darcha, Michèle Chevallier, et al.
Emerging Infectious Diseases
|
April 20, 2023
Unknown Circovirus in Immunosuppressed Patient with Hepatitis, France, 2022
Christophe Rodriguez, Laure Boizeau, Alexandre Soulier, et al.
Annals of Internal Medicine
|
November 15, 2016
Treatment With Ledipasvir-Sofosbuvir for 12 or 24 Weeks in Kidney Transplant Recipients With Chronic Hepatitis C Virus Genotype 1 or 4 Infection: A Randomized Trial
Massimo Colombo, Alessio Aghemo, Hong Liu, et al.
Gastroenterology
|
March 15, 2017
Efficacy and Safety of Sofosbuvir Plus Daclatasvir for Treatment of HCV-Associated Cryoglobulinemia Vasculitis
David Saadoun, Stanislas Pol, Yasmina Ferfar, et al.
Plos One
|
September 7, 2017
An in vitro diagnostic certified point of care single nucleotide test for IL28B polymorphisms
Darragh Duffy, Estelle Mottez, Shaun Ainsworth, et al.
Page
of 45
Search research articles
Search
Showing results (291-300 of 441) with videos related to
Sort By:
Page
of 45
Transplantation
|
March 22, 2018
Transmission of Hepatitis E Virus With Plasma Exchange in Kidney Transplant Recipients: A Retrospective Cohort Study
Vincent Mallet, Rebecca Sberro-Soussan, Anne-Marie Roque-Afonso, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
August 29, 2024
Alcohol Rehabilitation Within 3 Months After Alcohol Hepatitis and Survival: A National Analysis
Lucia Parlati, Charlotte Mouliade, Eric Nguyen Khac, et al.
Gastro Hep Advances
|
August 12, 2024
External Validation of LCR1-LCR2, a Multivariable Hepatocellular Carcinoma Risk Calculator, in a Multiethnic Cohort of Patients With Chronic Hepatitis B
Thierry Poynard, Jean Marc Lacombe, Olivier Deckmyn, et al.
Lancet (London, England)
|
April 4, 2015
Ombitasvir plus paritaprevir plus ritonavir with or without ribavirin in treatment-naive and treatment-experienced patients with genotype 4 chronic hepatitis C virus infection (PEARL-I): a randomised, open-label trial
Christophe Hézode, Tarik Asselah, K Rajender Reddy, et al.
JHEP Reports : Innovation in Hepatology
|
June 18, 2021
External validation of LCR1-LCR2, a multivariable HCC risk calculator, in patients with chronic HCV
Thierry Poynard, Jean Marc Lacombe, Olivier Deckmyn, et al.
European Journal of Gastroenterology & Hepatology
|
October 19, 2004
Histological response in patients treated by interferon plus ribavirin for hepatitis C virus-related severe fibrosis
Armand Abergel, Claude Darcha, Michèle Chevallier, et al.
Emerging Infectious Diseases
|
April 20, 2023
Unknown Circovirus in Immunosuppressed Patient with Hepatitis, France, 2022
Christophe Rodriguez, Laure Boizeau, Alexandre Soulier, et al.
Annals of Internal Medicine
|
November 15, 2016
Treatment With Ledipasvir-Sofosbuvir for 12 or 24 Weeks in Kidney Transplant Recipients With Chronic Hepatitis C Virus Genotype 1 or 4 Infection: A Randomized Trial
Massimo Colombo, Alessio Aghemo, Hong Liu, et al.
Gastroenterology
|
March 15, 2017
Efficacy and Safety of Sofosbuvir Plus Daclatasvir for Treatment of HCV-Associated Cryoglobulinemia Vasculitis
David Saadoun, Stanislas Pol, Yasmina Ferfar, et al.
Plos One
|
September 7, 2017
An in vitro diagnostic certified point of care single nucleotide test for IL28B polymorphisms
Darragh Duffy, Estelle Mottez, Shaun Ainsworth, et al.
Page
of 45